Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Starlight who wrote (6385)	5/28/1998 3:18:00 PM
From: Pseudo Biologist	Read Replies (3) \| Respond to of 17367

Betty, Centocor's drug Avakine is not for sepsis. Today they are looking for rec. on severe forms of a nasty autoimmune condition known as Crohn's disease. The drug is an antibody that recognizes TNF-alpha. The sepsis angle is that antibodies of this kind have been tested (Bayer/Celltech, perhaps others) for sepsis without success. Avakine is also in trials to treat less severe Crohn's as well as rheumatoid arthritis. I do not think Centocor is testing Avakine for sepsis at this time. PB